AU2001277023A1 - High affinity soluble interleukin-18 receptor - Google Patents

High affinity soluble interleukin-18 receptor

Info

Publication number
AU2001277023A1
AU2001277023A1 AU2001277023A AU7702301A AU2001277023A1 AU 2001277023 A1 AU2001277023 A1 AU 2001277023A1 AU 2001277023 A AU2001277023 A AU 2001277023A AU 7702301 A AU7702301 A AU 7702301A AU 2001277023 A1 AU2001277023 A1 AU 2001277023A1
Authority
AU
Australia
Prior art keywords
receptor
high affinity
soluble interleukin
affinity soluble
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277023A
Inventor
Stewart Leung
Neil Miyamoto
H. Daniel Perez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2001277023A1 publication Critical patent/AU2001277023A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001277023A 2000-07-20 2001-07-20 High affinity soluble interleukin-18 receptor Abandoned AU2001277023A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21944700P 2000-07-20 2000-07-20
US60219447 2000-07-20
US09/908,494 US20020052475A1 (en) 2000-07-20 2001-07-19 High affinity soluble interleukin-18 receptor
US09908494 2001-07-19
PCT/US2001/022863 WO2002008272A2 (en) 2000-07-20 2001-07-20 High affinity soluble interleukin-18 receptor

Publications (1)

Publication Number Publication Date
AU2001277023A1 true AU2001277023A1 (en) 2002-02-05

Family

ID=26913899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277023A Abandoned AU2001277023A1 (en) 2000-07-20 2001-07-20 High affinity soluble interleukin-18 receptor

Country Status (6)

Country Link
US (1) US20020052475A1 (en)
EP (1) EP1303607A2 (en)
JP (1) JP2004512026A (en)
AU (1) AU2001277023A1 (en)
NO (1) NO20030234L (en)
WO (1) WO2002008272A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137178A0 (en) * 1998-01-23 2001-07-24 Immunex Corp Il-18 receptors
EP1575513A4 (en) * 2002-08-16 2007-04-04 Wyeth Corp Compositions and methods for treating rage-associated disorders
ME01198B (en) * 2003-11-05 2013-03-20 Ares Trading Sa Process for the purification of il-18 binding protein
US20080292590A1 (en) * 2006-02-22 2008-11-27 Burkhard Becher Soluble Receptors and Methods for Treating Autoimmune or Demyelinating Diseases
JP5368301B2 (en) * 2006-06-22 2013-12-18 ノボ・ノルデイスク・エー／エス Soluble heterodimeric receptor and uses thereof
KR101361355B1 (en) 2007-06-14 2014-02-12 갈락티카 파마슈티칼스, 인크. Rage fusion proteins
EP2609117B1 (en) 2010-08-25 2015-09-16 F.Hoffmann-La Roche Ag Antibodies against il-18r1 and uses thereof
WO2014090800A1 (en) * 2012-12-10 2014-06-19 Vib Vzw Novel interleukin-33 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
IL137178A0 (en) * 1998-01-23 2001-07-24 Immunex Corp Il-18 receptors

Also Published As

Publication number Publication date
NO20030234L (en) 2003-03-18
WO2002008272A3 (en) 2002-04-18
NO20030234D0 (en) 2003-01-17
EP1303607A2 (en) 2003-04-23
US20020052475A1 (en) 2002-05-02
WO2002008272A2 (en) 2002-01-31
JP2004512026A (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU1456101A (en) Antibody diversity generation
AU2001228665A1 (en) Toll-like receptor
AU2001273728A1 (en) Arrangement for connecting planar components
AU2002213224A1 (en) Neurovascular stent
AU2001233626A1 (en) Marker
AU2001273032A1 (en) Cytokine receptor zcytor17
AU2002224866A1 (en) Homocinetic fixed joint
AU2002212018A1 (en) Service enabling technology
AU2001235435A1 (en) System for connecting elements
AU7540900A (en) Affinity macroligands
AU2001246934A1 (en) Agonist antibodies
AU7392501A (en) Connecting device
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AUPQ832200A0 (en) Pivot connection adjustment assembly
AU2001288156A1 (en) Beam adjusting device
AU2001277023A1 (en) High affinity soluble interleukin-18 receptor
AU2001279517A1 (en) Connecting device
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU7074401A (en) Movement joint
EP1185135A3 (en) Chinguard for headphone
AU2001289307A1 (en) Chemically-modified myelopoietin conjugates
AU2001223687A1 (en) Ball-and-socket joint
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU2001275667A1 (en) Homocinetic joint